<p>The most common major protocol deviations were ‘disallowed concurrent medications’ (15 patients in the placebo and 19 patients in the FCM group) and ‘selection criteria not met’ (5 patients in the placebo and 8 patients in the FCM group).</p
TURN* corresponds to the frequency of missing doses above which 75% of physicians’ estimates were lo...
Each horizontal bar represents the distribution (in percentage) of physicians’ estimates for a given...
<p>Four subjects in the Jinlida group and 2 subjects in the placebo group were excluded from the stu...
Eighty patients were excluded due to a treatment history of DM before KT. A further 118 patients wer...
<p>One hundred and four patients were screened, of whom 85 were included in the study. One patient w...
<p>CONSORT flowchart of participants through Study 2. There was a large difference in numbers analys...
<p>Study 1 was analyzed to discover brain connectivity predicting placebo response. All patients rec...
<p>Consort Patient flow chart: AmBisome® multi dose vs. single dose, ITT Intention to treat, PP per ...
<p>*, † These studies are not necessarily mutually exclusive; some met more than two research questi...
<p>The total number of articles and studies differs because one article reported two independent tri...
<p>*The modified intent-to-treat population was a subset of the intent-to-treat population that excl...
<p>Forty-seven patients were screened; 2 patients did not meet the eligibility criteria and so 45 we...
We excluded 18 patients who declined to participate and 12 patients who did not self-administer thei...
The design of a human Proof of Mechanism study to test the Mechanism of Action hypothesis. The phase...
Patients who were randomly assigned and received the intended treatment were analyzed for the outcom...
TURN* corresponds to the frequency of missing doses above which 75% of physicians’ estimates were lo...
Each horizontal bar represents the distribution (in percentage) of physicians’ estimates for a given...
<p>Four subjects in the Jinlida group and 2 subjects in the placebo group were excluded from the stu...
Eighty patients were excluded due to a treatment history of DM before KT. A further 118 patients wer...
<p>One hundred and four patients were screened, of whom 85 were included in the study. One patient w...
<p>CONSORT flowchart of participants through Study 2. There was a large difference in numbers analys...
<p>Study 1 was analyzed to discover brain connectivity predicting placebo response. All patients rec...
<p>Consort Patient flow chart: AmBisome® multi dose vs. single dose, ITT Intention to treat, PP per ...
<p>*, † These studies are not necessarily mutually exclusive; some met more than two research questi...
<p>The total number of articles and studies differs because one article reported two independent tri...
<p>*The modified intent-to-treat population was a subset of the intent-to-treat population that excl...
<p>Forty-seven patients were screened; 2 patients did not meet the eligibility criteria and so 45 we...
We excluded 18 patients who declined to participate and 12 patients who did not self-administer thei...
The design of a human Proof of Mechanism study to test the Mechanism of Action hypothesis. The phase...
Patients who were randomly assigned and received the intended treatment were analyzed for the outcom...
TURN* corresponds to the frequency of missing doses above which 75% of physicians’ estimates were lo...
Each horizontal bar represents the distribution (in percentage) of physicians’ estimates for a given...
<p>Four subjects in the Jinlida group and 2 subjects in the placebo group were excluded from the stu...
DOI
Add to ORKG